CastleArk Alternatives’s Crocs CROX Stock Holding History

CastleArk Alternatives’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-53,055	Closed	-$7.61M	–	76
2021 Q3	$7.61M	Buy	+53,055	New	+$7.28M	0.29%	93

Other funds holding CROX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CastleArk Alternatives's CROX Position: Q4 2021 in Review

CastleArk Alternatives sold out of Crocs (CROX) in Q4 2021, closing a stake of 53,055 shares — an estimated $7.61M sold.

CastleArk Alternatives first reported a position in CROX in Q3 2021 and held it in 1 quarter. The position peaked at $7.61M in Q3 2021. 435 funds tracked by Wall St. Rank hold CROX as of Q4 2021.

CastleArk Alternatives reported no remaining Crocs position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 53,055 Crocs shares in Q4 2021, an estimated $7.61M.
CastleArk Alternatives first reported a position in Crocs in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's Crocs position peaked at $7.61M in Q3 2021.
435 funds tracked by Wall St. Rank held Crocs as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.